ResMed Inc. ResMed Inc.

ResMed Inc.

RMD

Kedudukan dalam Saham #707
ResMed Inc. is a leading global medical technology enterprise engaged in the... ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Harga Saham
$245.97
Modal Pasaran
$34.59B
Perubahan (1 hari)
2.64%
Perubahan (1 tahun)
-9.38%
Negara
US
Perdagangan ResMed Inc. (RMD)

Kategori

Healthcare
Nisbah P/E bagi ResMed Inc. (RMD)
Nisbah P/E pada October 2026 TTM: 22.54
Menurut laporan kewangan dan harga saham terkini ResMed Inc., nisbah P/E semasa (TTM) ialah 22.54. Pada akhir 2024, syarikat mempunyai nisbah P/E sebanyak 26.92.
Sejarah nisbah P/E bagi ResMed Inc. dari 2000 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) 22.54 -16.59%
2025 27.02 0.38%
2024 26.92 -24.65%
2023 35.73 -9.05%
2022 39.28 -47.96%
2021 75.49 69.35%
2020 44.58 1.83%
2019 43.78 -6.58%
2018 46.86 45.70%
2017 32.16 27.81%
2016 25.16 12.14%
2015 22.44 8.16%
2014 20.75 -0.27%
2013 20.80 16.45%
2012 17.86 -14.08%
2011 20.79 -13.89%
2010 24.14 14.81%
2009 21.03 -16.13%
2008 25.07 -47.48%
2007 47.74 24.01%
2006 38.49 10.09%
2005 34.97 16.65%
2004 29.97 5.79%
2003 28.33 18.64%
2002 23.88 -82.35%
2001 135.33 272.77%
2000 36.30 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
33.11 46.91%
US
21.39 -5.10%
IE
28.94 28.43%
US
17.34 -23.07%
US
- -
DE
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.